SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

India’s hepatitis program targets elimination by 2030 but overlooks children, rural areas, and healthcare workers. Experts ...

Gilead has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy and Descovy. Biktarvy sales and Descovy ...

Vermont has the second lowest state fatality rate in the US (148.5 per 100K; Hawaii 114/100K). Mississippi (466.2/100K) and ...

Precision BioSciences Inc., a clinical-stage company developing gene editing therapies for diseases with high unmet need, has ...

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the second quarter of 2025, along with ...

Each year, July 28 is observed as World Hepatitis Day, as viral hepatitis continues to remain a public health threat, one of the primary causes of liver cancer ...

Question: I have heard that in some way COVID infection or having received the COVID vaccine is also a new risk for ...

Rates have been declining across the country, with all kindergartner coverage for each of the vaccines having dropped since ...

Unless we remove systemic discrimination, disadvantages and patriarchal barriers, how would we ensure that women and gender ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) have classified the hepatitis D virus (HDV) as carcinogenic to humans. HDV has joined hepatitis B and C ...